Cancer Drug for Alzheimer's Treatment Camp Lejeune NC

New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease. The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

Neil Mac Connell King, MD
100 Brewster Blvd
Camp Lejeune, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Eastern Va Med Sch Of The Med Coll Of Hampton Roads, Norfolk Va 23501
Graduation Year: 1993

Data Provided by:
Dr.Clarence Ballenger
(252) 633-3744
227 Memorial Drive
Jacksonville, NC
Gender
M
Speciality
Neurologist
General Information
Accepting New Patients: Yes
RateMD Rating
2.4, out of 5 based on 6, reviews.

Data Provided by:
Coastal Neurological Assoc
(910) 353-3624
227 Memorial Dr
Jacksonville, NC

Data Provided by:
Ronald L Follmer
(704) 446-1242
1000 Blythe Blvd
Charlotte, NC
Specialty
Neurology

Data Provided by:
Indravadan S Gatiwala, MD
(910) 739-2343
785 Oakridge Blvd
Lumberton, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Gov'T Med Coll, South Gujarat Univ, Surat, Gujarat, India
Graduation Year: 1981

Data Provided by:
Sean Hsu
(910) 577-4300
215 Station St
Jacksonville, NC
Specialty
Neurosurgery

Data Provided by:
Clarence Ballenger
(910) 353-3624
227 Memorial Dr
Jacksonville, NC
Specialty
Neurology, Alzheimer's Specialist

Osvaldo A Camilo
(704) 384-9437
1918 Randolph Rd
Charlotte, NC
Specialty
Neurology

Data Provided by:
Larry Steve Davidson, MD
(704) 792-2672
200 Medical Park Dr Ste 350
Concord, NC
Specialties
Neurological Surgery
Gender
Male
Education
Medical School: East Carolina Univ Sch Of Med, Greenville Nc 27858
Graduation Year: 1988

Data Provided by:
Robert Yapundich, MD
(828) 328-5500
1985 Tate Blvd SE Ste 600
Hickory, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Wv Univ Sch Of Med, Morgantown Wv 26506
Graduation Year: 1991

Data Provided by:
Data Provided by:

Cancer Drug for Alzheimer's Treatment

Provided By:

TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.

The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.

That process is critical in the process of recording new memories.

"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.

The findings appear in the September issue of the Journal of Alzheimer's Disease.

More information

Learn more about memory from McGill University.

SOURCE: Columbia University, news release, Sept. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com